PHIPL manufactures Sterile Injectables (SI) in state-of-the-art manufacturing facility for constant supply of medicines to the patients. Our patient centric approach helps us maintain best quality standards with Integrity and Compliance at its core. Manufacturing unit under PHIPL can deliver nearly 250 million units every year with Terminally Sterilized facility that can manufacture vials, emulsion and ampoules.
Our robust and most-advanced technical capabilities include automated solution compounding and clean-in-place, sterilize-in-place (CIP/SIP) systems, integrated high speed fill-finish lines, automated visual inspection and packaging lines with secondary- and tertiary-level serialization. Our products help treat, prolong and improve the quality of life of patients impacted by a broad range of life-limiting illnesses. PHIPL manufactures several injectable products which are listed as essential by the World Health Organization (WHO).
OUR PURPOSE AT PFIZER IS CLEAR: BREAKTHROUGHS THAT CHANGE PATIENTS’ LIVES. We realize that means not just attracting the best and brightest talent, but also ensuring our colleagues thrive in an environment and culture where we champion Diversity and Inclusion every day. PHIPL’s manufacturing unit has the youngest colleague-base in the Pfizer network.
We are committed towards best environment, health and safety, community development and colleagues’ well-being which is the key to creating an amazing workplace. While on the voyage to serve patients, we run several programs for sustainability at our manufacturing sites.